CB2cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies

  • Arévalo-Martín, D García-Ovejero, O Gómez, A Rubio-Araiz, B Navarro-Galve, C Guaza, E Molina-Holgado, F Molina-Holgado
  • British Journal of Pharmacology, January 2008, Wiley
  • DOI: 10.1038/sj.bjp.0707466

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Daniel Garcia-Ovejero